November 13, 2019
UCLA Health continues to transform cancer care
By uclahealth 
In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson Comprehensive Cancer Center (JCCC) has established an international reputation for providing the best in leading-edge and traditional cancer treatments […]
Tags: advanced lung cancer, breast cancer, CAR T cell therapy, Dr. Antoni Ribas, Dr. Arie Bellgedrun, Dr. Dennis Slamon, Dr. Edward Garon, Dr. Richard Finn, Dr. Sara Hurvitz, HER2-positive, HER2+, Herceptin
